Literature DB >> 12595743

Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early stage breast carcinoma.

Tracey L Colpitts1, Patricia Billing, Edward Granados, Mark Hayden, Steve Hodges, Lisa Roberts, John Russell, Paula Friedman, Steve Stroupe.   

Abstract

In this report we describe a cDNA sequence, BS106, identified from Incyte Genomics LifeSeq Expressed Sequence Tag database. A multi-tissue mRNA expression array, northern blots, and RT-PCR assays demonstrate the expression of BS106 in mammary, salivary and prostate glands, but not in other tissue types. BS106 mRNA was detected in 90% of the breast tissues examined. The cDNA encodes a 90-amino acid protein characterized as a small, mucin-like protein based on amino acid composition, extensive O-linked glycosylation, and expression profile. BS106 protein was recombinantly expressed in human embryonic kidney 293 cells and the secreted product was purified from the culture media. Monoclonal antibodies were prepared and used for immunohistochemical analysis of early stage breast cancer. BS106 protein was detected in the vast majority of carcinomas (70-100%) and overexpressed in approximately 30% of the 22 specimens analyzed. BS106 protein was not detected in other solid tumor types including bladder carcinoma, colon carcinoma, endometrial carcinoma, gastric carcinoma, squamous cell lung carcinoma, adenocarcinoma of the lung, ovarian carcinoma, pancreatic and prostatic carcinoma. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12595743     DOI: 10.1159/000068566

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  Expression of two breast-specific molecules in the lung.

Authors:  Florent Hube; Yvonne Myal; Etienne Leygue; Jerome Rollin; Yves Gruel
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

2.  Gene expression in human accessory lacrimal glands of Wolfring.

Authors:  John L Ubels; Ilene K Gipson; Sandra J Spurr-Michaud; Ann S Tisdale; Rachel E Van Dyken; Mark P Hatton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

3.  Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.

Authors:  Manuel Valladares-Ayerbes; Pilar Iglesias-Díaz; Silvia Díaz-Prado; Daniel Ayude; Vanessa Medina; Mar Haz; Margarita Reboredo; Silvia Antolín; Lourdes Calvo; Luis M Antón-Aparicio
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-17       Impact factor: 4.553

4.  Investigations with O-linked protein glycosylations by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Taufika Islam Williams; Diana A Saggese; Kristina L Toups; Jennifer L Frahm; Hyun Joo An; Bensheng Li; Carlito B Lebrilla; David C Muddiman
Journal:  J Mass Spectrom       Date:  2008-09       Impact factor: 1.982

5.  HER2 drives Mucin-like 1 to control proliferation in breast cancer cells.

Authors:  S J Conley; E E Bosco; D A Tice; R E Hollingsworth; R Herbst; Z Xiao
Journal:  Oncogene       Date:  2016-01-04       Impact factor: 9.867

6.  MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients.

Authors:  Juan Navarro-Barriuso; María José Mansilla; Bibiana Quirant-Sánchez; Alicia Ardiaca-Martínez; Aina Teniente-Serra; Silvia Presas-Rodríguez; Anja Ten Brinke; Cristina Ramo-Tello; Eva M Martínez-Cáceres
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

7.  Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins.

Authors:  Peter Arne Gerber; Peter Hevezi; Bettina Alexandra Buhren; Cynthia Martinez; Holger Schrumpf; Marcia Gasis; Susanne Grether-Beck; Jean Krutmann; Bernhard Homey; Albert Zlotnik
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

8.  Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.

Authors:  G P Skliris; F Hubé; I Gheorghiu; M M Mutawe; C Penner; P H Watson; L C Murphy; E Leygue; Y Myal
Journal:  Histopathology       Date:  2008-02       Impact factor: 5.087

9.  Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β‑catenin and increases irinotecan sensitivity in colorectal cancer.

Authors:  Maha Abdulla; Thamer Bin Traiki; Mansoor-Ali Vaali-Mohammed; Mohammad S El-Wetidy; Noura Alhassan; Khayal Al-Khayal; Ahmed Zubaidi; Omar Al-Obeed; Rehan Ahmad
Journal:  Int J Oncol       Date:  2022-01-21       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.